Investors finally get a glimpse of NeuroPace Inc (NPCE) volume hitting the figure of 0.53 million.

On Friday, NeuroPace Inc (NASDAQ: NPCE) was -3.23% drop from the session before settling in for the closing price of $14.23. A 52-week range for NPCE has been $5.45 – $17.47.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Annual sales at Healthcare sector company grew by 16.39% over the past five years. When this article was written, the company’s average yearly earnings per share was at 22.67%. With a float of $18.98 million, this company’s outstanding shares have now reached $29.78 million.

Let’s look at the performance matrix of the company that is accounted for 171 employees. In terms of profitability, gross margin is 73.83%, operating margin of -30.17%, and the pretax margin is -36.74%.

NeuroPace Inc (NPCE) Insider and Institutional Ownership

Also, it is sometimes useful to examine the sentiment of large-scale investors toward NeuroPace Inc stocks. The insider ownership of NeuroPace Inc is 47.78%, while institutional ownership is 33.53%. The most recent insider transaction that took place on Feb 20 ’25, was worth 49,545,943. In this transaction 10% Owner of this company sold 5,270,845 shares at a rate of $9.40, taking the stock ownership to the 0 shares. Before that another transaction happened on Jan 30 ’25, when Company’s CHIEF MEDICAL OFFICER sold 200 for $15.00, making the entire transaction worth $3,000. This insider now owns 86,762 shares in total.

NeuroPace Inc (NPCE) Latest Financial update

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.23 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 22.67% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.65% during the next five years compared to -0.33% drop over the previous five years of trading.

NeuroPace Inc (NASDAQ: NPCE) Trading Performance Indicators

You can see what NeuroPace Inc (NPCE) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.77. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.60.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.99, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.89 in one year’s time.

Technical Analysis of NeuroPace Inc (NPCE)

NeuroPace Inc (NASDAQ: NPCE) saw its 5-day average volume 0.7 million, a positive change from its year-to-date volume of 0.24 million. As of the previous 9 days, the stock’s Stochastic %D was 85.92%. Additionally, its Average True Range was 1.10.

During the past 100 days, NeuroPace Inc’s (NPCE) raw stochastic average was set at 86.13%, which indicates a significant increase from 84.63% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 60.13% in the past 14 days, which was lower than the 73.54% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $12.43, while its 200-day Moving Average is $8.79. Nevertheless, the first resistance level for the watch stands at $14.24 in the near term. At $14.70, the stock is likely to face the second major resistance level. The third major resistance level sits at $15.20. If the price goes on to break the first support level at $13.28, it is likely to go to the next support level at $12.78. The third support level lies at $12.32 if the price breaches the second support level.

NeuroPace Inc (NASDAQ: NPCE) Key Stats

There are 29,848K outstanding shares of the company, which has a market capitalization of 427.93 million. As of now, sales total 65,420 K while income totals -32,960 K. Its latest quarter income was 21,060 K while its last quarter net income were -5,450 K.